Deutsche Bank
ARLZ

Deutsche Bank’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Deutsche Bank’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-281,545
Closed -$99K – 5783
2018
Q2 		$99K Hold
281,545
– – ﹤0.01% 4555
2018
Q1 		$421K Sell
281,545
-88,700
-24% -$155K ﹤0.01% 3804
2017
Q4 		$524K Sell
370,245
-274,515
-43% -$451K ﹤0.01% 3573
2017
Q3 		$1.48M Sell
644,760
-60,447
-9% -$80.9K ﹤0.01% 2745
2017
Q2 		$951K Buy
705,207
+227,027
+47% +$328K ﹤0.01% 3067
2017
Q1 		$1.02M Buy
478,180
+195,499
+69% +$735K ﹤0.01% 2647
2016
Q4 		$1.25M Sell
282,681
-14,649
-5% -$69.5K ﹤0.01% 2558
2016
Q3 		$1.44M Sell
297,330
-191,662
-39% -$874K ﹤0.01% 2583
2016
Q2 		$1.61M Buy
488,992
+160,622
+49% +$606K ﹤0.01% 2554
2016
Q1 		$1.16M Buy
+328,370
New +$1.69M ﹤0.01% 2722

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Deutsche Bank's ARLZ Position: Q3 2018 in Review

Deutsche Bank sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 281,545 shares — an estimated $99K sold.

Deutsche Bank first reported a position in ARLZ in Q1 2016 and held it in 10 quarters. The position peaked at $1.61M in Q2 2016. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Deutsche Bank reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Deutsche Bank sold 281,545 Aralez Pharmaceuticals Inc. shares in Q3 2018, an estimated $99K.
  • Deutsche Bank first reported a position in Aralez Pharmaceuticals Inc. in Q1 2016 and held it in 10 quarters.
  • Deutsche Bank's Aralez Pharmaceuticals Inc. position peaked at $1.61M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Deutsche Bank's 13F filing for Q3 2018, filed 14 Nov 2018.